Biologist by training, following short time in pharmaceutical industry, I joined the EMA’s Pharmaceutical Quality Office in 2013. Points of interest include CMC aspects of Advanced Therapy Medicinal Products (CRISPR), biotechnological products, bacteriophages and microbiome based therapies.